gliotoxin has been researched along with Pancreatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Driscoll, H; Jackman, S; Larsen, B; Liu, H | 1 |
| Arlt, A; Breitenbroich, M; Fölsch, UR; Kalthoff, H; Schäfer, H; Schmidt, WE; Vorndamm, J | 1 |
2 other study(ies) available for gliotoxin and Pancreatic Neoplasms
| Article | Year |
|---|---|
Effect of gliotoxin on development of diabetes mellitus in diabetes-prone BB/Wor rats.
Topics: Animals; Autoimmunity; Blood Glucose; Diabetes Mellitus, Type 1; Female; Gliotoxin; Immunosuppressive Agents; Insulin; Insulin Secretion; Insulinoma; Macrophages; Male; Pancreatic Neoplasms; Rats; Rats, Inbred BB; Tumor Cells, Cultured; Weight Gain | 2000 |
Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin.
Topics: Antineoplastic Agents; Carcinoma; DNA-Binding Proteins; Doxorubicin; Drug Resistance; Etoposide; Gliotoxin; Humans; I-kappa B Proteins; Leupeptins; NF-kappa B; NF-KappaB Inhibitor alpha; Pancreatic Neoplasms; Sulfasalazine | 2001 |